CardioFlow to acquire MicroPort Cardiac Rhythm Management

CardioFlow (02160) announced a merger agreement to acquire MicroPort Cardiac Rhythm Management (a subsidiary of MicroPort Scientific) for a valuation of $680 million. The acquisition will be effected through a merger, with CardioFlow issuing new shares as consideration.

“本公司将以合并方式收购目标公司，合并附属公司及目标公司将于生效时间合并并作为一家公司存续”beta.zhitongcaijing.com

• 1 source
• beta.zhitongcaijing.com心通医疗-B(02160)、合并附属公司及微创心律管理就交易订立合并协议Sep 29, 2025

Summarized from public sources; check the original articles before acting on it.